Domka, K., Dąbkowska, A., Janowska, M., Urbańska, Z., Pastorczak, A., Winiarska, M., Fidyt, K., Lachota, M., Patkowska, E., Sędek, Łukasz, Perkowski, B., Hunia, J., Jakubowska, J., Krzymieniewska, B., Lech-Marańda, E., Młynarski, W., Szczepański, T. and Firczuk, M. (2024) “Asciminib stands out as the superior tyrosine kinase inhibitor to combine with anti-CD20 monoclonal antibodies for the treatment of CD20<sup>+</sup&gt; Philadelphia-positive B-cell precursor acute lymphoblastic leukemia in preclinical models”, Haematologica. Pavia, Italy, 109(11), pp. 3520-3532. doi: 10.3324/haematol.2023.284853.